Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Hair loss has been documented with various GLP-1 and GIP/GLP-1 agents, though causality and whether this represents a true class effect remain unproven
Sometimes coverage is available for other FDA-approved uses, such as Zepbound for obstructive sleep apnea or Wegovy for cardiovascular protection
DMSO effects on cellular processes were analyzed using full transcriptome data
Microdosing refers to the practice of using a dose smaller than the standard prescription
Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Should not be used alongside other GLP-1 receptor medications Gastric emptying may be delayed, requiring caution for procedures involving sedation or general anesthesia due to aspiration risk Use caution in those with a history of diabetic retinopathy 1-3 Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions Avoid use during pregnancy and breastfeeding 1 Enhances glucose-dependent insulin secretion Suppresses glucagon secretion Slows gastric emptying Influences brain regions involved in appetite regulation, leading to reduced hunger and caloric intake Improves insulin sensitivity 1-3 Supports weight loss Helps to minimize internal inflammation and improves cardiometabolic health measures 5 Q: How long does it take to see results
Although Mounjaro can produce greater average weight loss results, some people switch to Wegovy for its cardiovascular benefits or because their bodies tolerate a single GLP-1 agonist better than the dual GLP-1 and GIP agonist effects of Mounjaro
